Novo Nordisk A/S
Factor VIII variants having a decreased cellular uptake
Last updated:
Abstract:
The present invention relates to modified coagulation factors. In particular, the present invention relates to modied Factor VIII molecules having decreased cellular uptake.
Status:
Grant
Type:
Utility
Filling date:
6 Jul 2018
Issue date:
2 Feb 2021